Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Revenue

Fredun Pharmaceuticals had revenue of 1.44B INR in the quarter ending September 30, 2025, with 33.75% growth. This brings the company's revenue in the last twelve months to 5.31B, up 35.96% year-over-year. In the fiscal year ending March 31, 2025, Fredun Pharmaceuticals had annual revenue of 4.54B with 30.35% growth.

• Revenue (ttm): 5.31B
• Revenue Growth: +35.96%
• P/S Ratio: 1.34
• Revenue / Employee: 20.33M
• Employees: 261
• Market Cap: 7.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4.54B	1.06B	30.35%
Mar 31, 2024	3.48B	734.81M	26.75%
Mar 31, 2023	2.75B	502.16M	22.37%
Mar 31, 2022	2.24B	906.43M	67.74%
Mar 31, 2021	1.34B	211.22M	18.74%